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Abstract FRS2K and FRS2L, two members of the FRS2 fam-
ily of docking proteins, become tyrosine phosphorylated in re-
sponse to ¢broblast growth factor (FGF) or nerve growth factor
(NGF) stimulation. Tyrosine phosphorylated FRS2K serves as a
platform for the recruitment of multiple signaling proteins for
activation of the Ras-mitogen-activated protein (MAP) kinase
signaling cascade. We report that Frs2K and Frs2L have distinct
spatio-temporal expression patterns in mouse embryos. We fur-
ther show that FRS2L can compensate for the loss of FRS2K
for activation of MAP kinase when expressed in ¢broblasts
from Frs2K3/3 mouse embryos. We propose that the FRS2
family proteins have distinct roles in vivo through activation
of common signaling proteins including MAP kinase.
* 2004 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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1. Introduction
Docking proteins FRS2K and FRS2L play important roles
in mediating the intracellular signals induced by ¢broblast
growth factors (FGFs) and members of the nerve growth
factor (NGF) and glial cell-derived neurotrophic factor fam-
ilies of neurotrophins [1^5]. FRS2K acts as a platform for
direct and indirect recruitment of a variety of signaling pro-
tein complexes to regulate a diverse array of cellular re-
sponses. We created a targeted deletion of the Frs2K gene in
mice and showed that FRS2K de¢ciency causes embryonic
lethality at embryonic day (E)7^7.5 due to a defect in FGF4
signaling for development of trophoblast tissues, underscoring
the critical role of FRS2K in early embryogenesis ([6] and
unpublished results). FGFs and neurotrophins are involved
in development of multiple tissues including those of the ner-
vous system, and it is possible that FRS2K also plays an
important role in the development of these tissues [7,8].
We used ¢broblasts from Frs2K3=3 embryos to show that
FRS2K plays an important role in mediating multiple FGF-
induced cellular responses including stimulation of mitogen-
activated protein (MAP) kinase and phosphatidylinositol (PI)-
3 kinase [6]. In addition to the central role of MAP kinase in
FGF-induced cell proliferation and di¡erentiation, MAP ki-
nase plays a key role in a negative feedback mechanism in
which MAP kinase phosphorylates multiple threonine resi-
dues in FRS2K [9]. The mechanisms of intracellular signaling
through FRS2L remain unclear.
In the present study, we examined the expression patterns
of Frs2K and Frs2L in mouse embryos by in situ hybridiza-
tion. We also examined the possibility that FRS2K and
FRS2L have redundant roles in signaling via FGF receptors
(FGFRs) through ectopic expression of FRS2L in Frs2K3=3
mouse embryonic ¢broblasts (MEFs) that are also de¢cient in
FRS2L.
2. Materials and methods
2.1. Cloning of FRS2L cDNA and in situ hybridization
Human FRS2L full-length cDNA was cloned by screening the hu-
man brain cDNA library (Clontech) with a V1-kb partial fragment
of human FRS2L cDNA from an EST clone. Full-length cDNA of
mouse Frs2L was cloned by screening the mouse brain cDNA library
(Clontech) with a V500-bp fragment of human FRS2L cDNA. For
whole-mount RNA in situ hybridization experiments, the mouse
Frs2K cDNA fragment linearized with HpaI or the mouse Frs2L
full-length cDNA linearized with BamHI were used as speci¢c probes.
For section RNA in situ hybridization experiments, mouse Frs2K or
Frs2L cDNAs were linearized with NotI or BamHI, respectively, and
then used as speci¢c probes. Antisense riboprobes and sense ribo-
probes were synthesized with digoxigenin (DIG)-coupled uridine tri-
phosphate (UTP) (Boehringer-Mannheim). Whole-mount RNA in
situ hybridization was performed essentially as described [10]. Section
RNA in situ hybridization was performed essentially as described [11].
BM purple was used as a substrate for alkaline-phosphatase-coupled
anti-DIG antibodies (Boehringer-Mannheim). After hybridization, the
sections were counterstained with Nuclear Fast Red (Vector Lab.).
2.2. Cell culture and generation of MEFs expressing FRS2L
MEFs derived from Frs2K3=3 embryos and human embryonic kid-
ney (HEK) 293 cells were grown in Dulbecco’s modi¢ed Eagle’s me-
dium (DMEM) with 10% fetal calf serum (FBS) from Gibco BRL as
previously described [6]. FRS2L cDNA with a Myc tag attached to the
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C-terminus of FRS2L was cloned into the mammalian expression
vector pBABE and a high-titer virus stock was produced as described
previously [2]. Frs2K3=3 MEFs were infected with retrovirus contain-
ing pBABE alone or FRS2L cDNA that was cloned into pBABE and
selected for 2 weeks in medium supplemented with puromycin (1 Wg/
ml). Pools of selected cultures were used for experiments. HEK 293
cells were transfected using lipofectamine (Invitrogen) according to
the manufacturer’s protocol.
2.3. Immunoprecipitation and immunoblot analysis
Cells were starved overnight in 0.5% serum and stimulated with
FGF1 (100 ng/ml) together with heparin (5 Wg/ml) for 5 min at
37‡C. Subsequently, the cells were lysed and subjected to immunopre-
cipitation followed by immunoblotting as described [12]. Anti-FRS2,
anti-Shp2, anti-phosphotyrosine, anti-Grb2, anti-phospho-speci¢c Erk
and anti-Erk antibodies were described previously [12]. Anti-Myc tag
antibody, clone 9E10, was purchased form Upstate Biotechnology.
3. Results and discussion
3.1. Expression of Frs2K and Frs2L in mouse embryos
The patterns of expression of Frs2K and Frs2L were com-
pared by in situ hybridization of mouse embryos at di¡erent
stages of development. Whole-mount in situ hybridization of
E8.5 embryos with antisense probe for Frs2K revealed high
levels of ubiquitous expression of Frs2K transcript in the em-
bryo (Fig. 1A), whereas levels of expression of Frs2L were not
above background in any areas of the embryos (Fig. 1C).
Sense probes for Frs2K and Frs2L were used as controls for
speci¢city of in situ hybridization experiments (Fig. 1B and
data not shown). We also performed in situ hybridization of
Frs2K on frozen sagittal sections of embryos at E9.5 and
E11.5. We found that at E9.5, Frs2K is expressed ubiquitously
in most developing tissues (Fig. 1D), whereas Frs2L expres-
sion was negligible (Fig. 1F). Sense probes for Frs2K and
Frs2L were used as controls for speci¢city of in situ hybridi-
zation experiments (Fig. 1E and data not shown).
As shown in Fig. 1G, at E11.5 Frs2K transcripts were
present in many developing tissues, including the ¢rst and
second branchial arches (such as tongue and jaw), neuro-
epithelium of the brain (arrowheads), hepatic parenchyma,
midgut, and precartilage primordium of the vertebrae and
hindlimb (Fig. 1G). We also observed cells that only showed
C
Fig. 1. Expression of Frs2K and Frs2L in mouse embryos. Whole-
mount in situ hybridization with Frs2K antisense probe of mouse
embryos (A^C). In situ hybridization for frozen sagittal sections of
embryos (D^N). Speci¢c binding of the antisense probes is visible as
blue or violet staining (A^N). The same sections were counter-
stained with Nuclear Fast Red to visualize tissue structures (D^N).
Embryonic stages and antisense probes used for staining are indi-
cated in each image. We used adjacent sections in D, E and F, G
and H, I and J, and K and L, and M and N. Arrowheads in G
and H indicate VZ of the neuroepithelium. An arrow in J indicates
lung epithelium. An arrow in M indicates metanephric mesenchyme.
Arrowheads in M and N indicate tubuli or s- or comma-shaped pre-
tubular structure of the metanephric kidney. FB, forebrain; MB,
midbrain; HB, hindbrain; OP, otic pit ; 1st Br, ¢rst branchial arch;
H, heart; NT, neural tube; TV, telencephalic vesicle; MV, mesence-
phalic vesicle; 4th V, fourth ventricle; T, tongue; J, jaw; 2nd Br,
second branchial arch; AC, atrial chamber; VC, ventricular cham-
ber; Ve, precartilage primordium of vertebrae; HP, hepatic paren-
chyma; MG, midgut; St, stomach; HL, hindlimb; V, trigeminal
ganglion; VII/VIII, facial (VII)^acoustic (VIII) ganglion complex;
IX/X, glossopharyngeal^vagus ganglion complex; R, cartilage pri-
mordium of ribs; LB, lung bud; SC, spinal cord; M, metanephric
kidney. (For interpretation of the references to colour in this ¢gure
legend, the reader is referred to the web version of this article.)
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the pink counterstaining in the chambers of the heart and
venous sinusoids lining the gap of loose hepatic parenchyma
(Fig. 1G, *). These cells appeared to be primitive nucleated
red blood cells and did not express Frs2K at a detectable level.
Strong expression of Frs2L was detected predominantly in the
neuroepithelium at E11.5 (Fig. 1H, arrow). Frs2L was also
expressed in dorsal root ganglia (DRG) and in cranial ganglia
such as the trigeminal (V) ganglia (Fig. 1H, inset).
In situ hybridization of embryos at E14.5 revealed ubiqui-
tous expression of Frs2K. Frs2K was strongly expressed in the
lung bud, cartilage primordium of ribs, DRG and spinal cord
(Fig. 1I). Frs2K was also expressed strongly in the metaneph-
ric mesencyme, tubuli and s- or comma-shaped pretubular
structure of the metanephric kidney and stomach epithelium
(Fig. 1K, M). At E14.5, Frs2L was expressed at high levels in
neural tissues in DRG and spinal cord and in several tissues
such as lung epithelium (Fig. 1J) and tubuli and s- or comma-
shaped pretubular structure of the metanephric kidney (Fig.
1L, N).
These results indicate that Frs2K is expressed in most devel-
oping tissues, whereas Frs2L is expressed predominantly in the
developing neuroepithelium.
3.2. Distinct patterns of expression of Frs2K and Frs2L in
embryonic brain
To further analyze the expression of Frs2K and Frs2L in
neural tissues, we compared the patterns of expression of
these genes in coronal sections of the heads of E14.5 embryos.
We observed strong expression of both transcripts in the brain
and trigeminal ganglia (V) (Fig. 2A^D). Frs2K was also ex-
pressed in other tissues such as cartilage primordium (Fig. 2C,
arrowhead). The layer adjacent to a ventricle is ventricular
zone (VZ) and is composed of germinal neuroepithelium con-
taining immature neuroblasts and glioblasts. Once cells in this
region stop dividing, they migrate away from the ventricle and
begin to di¡erentiate [13]. At E14.5, Frs2K but not Frs2L was
expressed strongly in the VZ surrounding the lateral ventricles
and the mesencephalic vesicle (Fig. 2A^D, *). The reciprocal
pattern of expression of both genes was also seen in the
neuroepithelium at E11.5 (Fig. 1G, H, arrowheads). We
next analyzed expression of Frs2K and Frs2L in coronal sec-
tions of brain of E18.5 embryos. Both Frs2K and Frs2L were
expressed in the cortical plate and cortical subplate in the
cingulate and parietal cortices and caudate putamen (Fig.
2E^H). Strong expression of Frs2L was observed in the lateral
septal nucleus, thalamus and hypothalamus, whereas Frs2K
was expressed at low levels in these areas of the brain (Fig.
2E^J). Finally, both genes were expressed in the CA1, CA2,
and CA3 regions of the developing hippocampus and in den-
tate gyrus (Fig. 2I, J).
3.3. FRS2L rescues a defect in MAP kinase stimulation in
Frs2K3=3 cells
We next examined whether FRS2L mediates cellular re-
sponses previously shown to be mediated by FRS2K in re-
sponse to FGF stimulation. Transient coexpression experi-
ments in HEK 293 cells were performed with vectors
expressing FLAG-tagged FRS2K or FRS2L and vectors ex-
pressing FGFR1 or NGF receptor (NGFR). Both FRS2K and
FRS2L were tyrosine phosphorylated and formed complexes
with Grb2 in response to FGF or NGF (Fig. 3A). Both
FRS2K and FRS2L bound activated and tyrosine phosphor-
ylated FGFR and NGFR (Fig. 3A). As previously shown,
FRS2K but not FRS2L was phosphorylated on threonine res-
idues resulting in reduced electrophoretic mobility (Fig. 3B).
We also expressed Myc-tagged FRS2L in MEFs derived from
Frs2K3=3 embryos. Lysates from unstimulated or FGF-stimu-
lated cells were subjected to immunoprecipitation with anti-
Myc antibodies followed by immunoblotting with anti-FRS2,
anti-phosphotyrosine, anti-Grb2, or anti-Shp2 antibodies. As
shown in Fig. 3C and D, FGF stimulation induced tyrosine
Fig. 2. Expression of Frs2K and Frs2L in heads of E14.5 and E18.5
embryos. In situ hybridization for frozen coronal sections of heads.
Embryonic stages and antisense probes used for staining are indi-
cated in each image. Images in A and B, C and D, E and F, and G
and H are from single sections, respectively. In the head of embryos
at E18.5, compared with the midline, sections in E^H are anterior,
and sections in I and J are posterior. LV, lateral ventricle; Ht, hy-
pothalamus; Cg, cingulate cortex; LS, lateral septal nucleus; CPu,
caudate putamen; CxP, cortical plate; CxS, cortical subplate; PC,
parietal cortex; Th, thalamus; DG, denta gyrus.
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phosphorylation of FRS2L as well as complex formation be-
tween FRS2L and Grb2 and Shp2. We previously showed that
FGF-induced stimulation of MAP kinase was compromised
in Frs2K3=3 cells. We next examined whether ectopic expres-
sion of FRS2L in FRS2-de¢cient MEFs rescues the MAP ki-
nase response in response to FGF. Frs2K3=3 MEFs express-
ing FRS2L or FRS2K or vector-transfected Frs2K3=3 MEFs
were stimulated with FGF, and activation of MAP kinase was
monitored by immunoblotting of lysates from unstimulated or
stimulated cells with anti-phospho-Erk antibodies. As re-
Fig. 3. FGF and NGF induce tyrosine phosphorylation of FRS2L in transfected cells. A: HEK 293 cells were cotransfected with vectors ex-
pressing FRS2K-FLAG or FRS2L-FLAG and vectors expressing FGFR1 or NGFR. Lysates from unstimulated or stimulated cells were sub-
jected to immunoprecipitation with anti-FLAG antibodies, anti-receptor antibodies followed by immunoblotting with anti-FRS2, anti-Grb2 and
anti-phosphotyrosine antibodies (p-Tyr). B: HEK 293 cells were cotransfected with vectors expressing FRS2K-FLAG or FRS2L-FLAG (top
panel) and vector expressing FGFR1. Lysates from unstimulated or stimulated cells were immunoprecipitated with anti-FLAG antibodies and
immunoblotted with antibodies directed against a consensus MAP kinase phosphorylation site, (designated p-Thr), anti-phosphotyrosine anti-
bodies, or anti-FLAG antibodies. Lysates from HEK 293 cells that were transfected with expression vectors that direct the synthesis of FRS2K,
FRS2L, the chimeric K/L FRS2 or the chimeric L/K FRS2 were subjected to immunoblotting with anti-phosphotyrosine antibodies (bottom pan-
el). C, D: Lysates from unstimulated or FGF1-stimulated Frs2K3=3 MEFs or MEFs expressing FRS2L-Myc were subjected to immunoprecipi-
tation with anti-Myc or anti-Shp2 antibodies followed by immunoblotting with the indicated antibodies.
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ported previously, FGF-induced stimulation of MAP kinase
in vector-transfected Frs2K3=3 cells was weak and transient
(Fig. 4, top panel), whereas FGF stimulation of Frs2K3=3
cells expressing FRS2K resulted in rapid and sustained acti-
vation of MAP kinase (Fig. 4, top and third panels) [6]. Sim-
ilarly, a strong and sustained MAP kinase response was
observed in FRS2L-expressing Frs2K3=3 cells (Fig. 4, third
panel). Moreover, the MAP kinase response was somewhat
more robust in cells expressing FRS2L in comparison with
that of cells expressing FRS2K. Similarly, FGF-induced
MAP kinase activation mediated by FRS2L was more robust
than that mediated by FRS2K in HEK 293 cells (Fig. 3B,
bottom panel). We also expressed two previously described
chimeric proteins designated FRS2K/L and FRS2L/K in
HEK 293 cells [9]. The former has the PTB domain of
FRS2K and the C-terminal region of FRS2L, and the latter
has the PTB domain of FRS2L and the C-terminal region of
FRS2K. We found that MAP kinase activation was stronger
in cells expressing FRS2K/L or FRS2L than in cells expressing
FRS2L/K or FRS2K (Fig. 3B, bottom panel). These ¢ndings
indicate that FRS2L can compensate for the loss of FRS2K in
mediating the MAP kinase response to FGF stimulation and
that FRS2L may yield a stronger MAP kinase response than
does FRS2K in response to FGF stimulation.
FRS2L, unlike FRS2K, is not phosphorylated on threonine
residues in response to FGF stimulation because it lacks ca-
nonical MAP kinase phosphorylation sites (Fig. 3B) [9]. The
sustained activation of MAP kinase stimulation seen in
Frs2K3=3 MEFs expressing FRS2L is particularly striking as
the expression of FRS2L was much lower than the expression
of FRS2K in those cells (data not shown). It is possible that
the loss of MAP kinase-induced negative feedback on FRS2L
enables FRS2L to function signi¢cantly at lower levels of ex-
pression and to transmit a stronger signal for activation of
MAP kinase than does FRS2K in response to growth factor
stimulation.
In the present study, we found that FRS2K and FRS2L
have overlapping roles in FGF-induced activation of MAP
kinase, although FRS2L may activate MAP kinase more
strongly than does FRS2K. In contrast, expression of the tran-
scripts for these proteins is regulated developmentally in a
distinct manner.
Our results suggest that FRS2K is involved in the develop-
ment of multiple tissues, whereas FRS2L activity appears to
be limited to development of a few tissues, including those of
the nervous system. The localization of Frs2K in the VZ of the
developing nervous system is particularly interesting, because
this layer contains neural stem cells that can self-renew in
response to FGF [14] (Figs. 1G, 2A, C). FRS2L may play a
more signi¢cant role in the development of thalamus and
hypothalamus than does FRS2K (Fig. 2I, J).
In conclusion, we propose that the distinct spatial and tem-
poral patterns of expression of FRS2K and FRS2L dictate
their physiological role(s) in vivo and that FRS2K and
FRS2L mediate overlapping cellular responses following
growth factor stimulation.
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Fig. 4. Rescue of FGF-induced MAP kinase stimulation in FRS2K-
de¢cient cells by ectopic expression of FRS2L. Frs2K3=3 MEFs ex-
pressing FRS2K or FRS2L or vector-transfected Frs2K3=3 were
starved overnight and stimulated with FGF1. Lysates from unstimu-
lated or stimulated cells were resolved by sodium dodecyl sulfate^
polyacrylamide gel electrophoresis (SDS^PAGE) and immunoblotted
with anti-phospho-Erk or anti-Erk antibodies.
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